HCTI · XBRL financial data
Healthcare Triangle financial statements, every quarter
The same tables from 14 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (HCTI's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | †Dec 31, 2024 | †Mar 31, 2025 | †Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 7* | 4 | 3 | 2 | 2* | 4 | 4 | 3 | 3* | 10 | 9 |
| Cost of revenue | 6 | 6* | 3 | 2 | 2 | 2* | 3 | 3 | 3 | 3* | 7 | 7 |
| Gross profit | — | year only | 1,070 | — | — | — | 1,070 | 0 | — | — | — | 2 |
| Research and development | 0 | 0* | 0 | 0 | 0 | (0)* | 0 | 0 | 0 | 0* | 0 | 0 |
| General and administrative | 1 | 1* | 1 | 1 | 1 | 1* | 1 | 1 | 2 | 3* | 3 | 5 |
| Total operating expenses | 3 | 3* | 3 | 2 | 2 | 1* | 2 | 2 | 3 | 5* | 6 | 6 |
| Operating income (loss) | (2) | (1)* | (2) | (1) | (1) | (0)* | (1) | (1) | (3) | (4)* | (4) | (4) |
| Interest expense | (0) | 0* | (0) | (0) | (0) | — | 0 | 0* | 0* | 0* | 0 | 0* |
| Income tax expense (benefit) | 0 | 0* | 0 | 0 | 0 | 0* | — | — | — | — | — | 0 |
| Net income (loss) | (2) | (2)* | (2) | (2) | (1) | (1)* | (2) | (1) | (2) | (5)* | (6) | (4) |
| Earnings per share, basic USD per share | (0.45) | (0.42)* | (0.42) | (0.28) | (0.22) | (0.24)* | (0.17) | (0.58) | (0.42) | — | (6.81) | (1.56) |
| Earnings per share, diluted USD per share | (0.45) | (0.42)* | (0.42) | (0.28) | (0.22) | (0.24)* | (0.17) | (0.58) | (0.42) | — | (6.81) | (1.56) |
| Weighted average shares, basic millions of shares | 4 | 4* | 4 | 5 | 6 | 6* | 10 | 2 | 4 | — | 1 | 3 |
| Weighted average shares, diluted millions of shares | 4 | 4* | 4 | 5 | 6 | 6* | 10 | 2 | 4 | — | 1 | 3 |
- † Share count changed about 8x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 9x in the period ending 2025-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/70 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal quarters (HCTI's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | †Dec 31, 2024 | †Mar 31, 2025 | †Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | 0 | 1 | 0 | 0 | 0 | 0 | 7 | 3 | 2 | 8 | 4 | 2 |
| Accounts receivable | 0 | 4 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 8 | 6 |
| Total current assets | 5 | 6 | 3 | 2 | 2 | 1 | 10 | 9 | 8 | 13 | 19 | 10 |
| Property and equipment, net | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 | 0 | 1 | 1 |
| Right-of-use asset | — | — | — | — | — | — | — | — | — | — | 1 | 1 |
| Goodwill | 1 | — | — | — | — | — | — | — | — | 3 | 3 | 3 |
| Total assets | 14 | 7 | 7 | 6 | 5 | 2 | 12 | 15 | 14 | 23 | 80 | 74 |
| Accounts payable | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 3 | 1 |
| Accrued liabilities | — | — | — | — | — | — | — | — | — | — | 0 | — |
| Current portion of long-term debt | — | — | — | — | — | — | — | — | — | — | 8 | 5 |
| Total current liabilities | 7 | 8 | 6 | 6 | 6 | 7 | 3 | 3 | 4 | 13 | 21 | 16 |
| Long-term debt | — | — | — | — | — | — | — | — | — | — | 1 | — |
| Lease liability, non-current | — | — | — | — | — | — | — | — | — | — | 1 | 1 |
| Total liabilities | 8 | 8 | 7 | 7 | 7 | 7 | 3 | 4 | 5 | 13 | 27 | 25 |
| Accumulated deficit | (20) | (28) | (27) | (28) | (30) | (34) | (35) | (37) | (39) | (43) | (49) | (53) |
| Total stockholders' equity | 6 | (1) | (1) | (1) | (2) | (5) | 9 | 10 | — | — | — | — |
| Total liabilities and equity | 14 | 7 | 7 | 6 | 5 | 2 | 12 | 15 | 14 | 23 | 80 | 74 |
| Common shares outstanding (cover page) millions of shares | 4 | 5 | 6 | 6 | 6 | 45 | 408 | 6 | 7 | 2 | 2 | 15 |
- † Share count changed about 8x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 9x in the period ending 2025-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/70 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal quarters (HCTI's year ends in late December)
| In millions of dollars | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | †Dec 31, 2024 | †Mar 31, 2025 | †Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | Mar 31, 2026 | Jun 30, 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) | (2) | (2)* | (2) | (2) | (1) | (1)* | (2) | (1) | (2) | (5)* | (6) | (4) |
| Stock-based compensation | 0* | (0)* | 0 | 0* | 0* | (0)* | 0 | 0* | 0* | 0* | — | — |
| Depreciation and amortization | 1* | (1)* | 1 | 0* | 0* | (0)* | 0 | 0* | 0* | 1* | 1 | 1* |
| Net cash from operating activities | 0* | 1* | (0) | (1)* | 1* | (1)* | (6) | (3)* | (1)* | (7)* | (7) | (1)* |
| Purchases of property and equipment | 0* | 0* | — | — | — | — | — | — | 0* | 0* | 0 | — |
| Net cash from investing activities | (0)* | (0)* | — | — | — | — | — | — | (1)* | (0)* | (6) | (3)* |
| Proceeds from issuing common stock | — | year only | — | — | — | — | — | — | — | year only | 0 | — |
| Proceeds from issuing equity | — | — | — | — | — | year only | 14 | 0* | — | year only | 9 | 1* |
| Proceeds from long-term debt | — | — | — | — | — | — | — | — | — | — | 0 | — |
| Net cash from financing activities | (0)* | 0* | (1) | 1* | (1)* | 1* | 12 | (0)* | 1* | 13* | 9 | 2* |
| Net change in cash | — | — | — | — | — | — | 7 | (4)* | — | — | (3) | (2)* |
- † Share count changed about 8x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 9x in the period ending 2025-03-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/70 in the period ending 2025-06-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 7373 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 7373 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Healthcare Triangle | 1.9 | 9.2 | (0.8)* | 15.0M | 2.3 quarters | 10-QJun 30, 2026 |
| Veea | 1.9 | 0.2 | (5.9)* | 62.2M | 0.3 quarters | 10-QJun 30, 2026 |
| Nixxy | 0.3 | 16 | (1)* | 28.9M | 1.8 quarters | 10-QJun 30, 2026 |
| RideNow Group | 47 | 297 | (0.1)* | not reported | 467.0 quarters | 10-QJun 30, 2026 |
| Airwa | 11 | 21 | 28 | 4.6M | — | 10-QJul 31, 2026 |
| Cloudastructure | 3.8 | 1.2 | (1.9)* | not reported | 2.0 quarters | 10-QJun 30, 2026 |
| BioScience Health Innovations | 0.7 | 1 | (0.5)* | 11.8M | 1.3 quarters | 10-QJun 30, 2026 |
| Avai Bio | 0.1 | not reported | (0.4) | 153.9M | 0.2 quarters | 10-QJun 30, 2026 |
| Marketwise | 33 | 76 | 22* | not reported | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.